🇺🇸 Gelol in United States
20 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 20
Most-reported reactions
- Pain — 3 reports (15%)
- Pain In Extremity — 3 reports (15%)
- Abasia — 2 reports (10%)
- Cataract — 2 reports (10%)
- Drug Ineffective — 2 reports (10%)
- Musculoskeletal Pain — 2 reports (10%)
- Osteoporosis — 2 reports (10%)
- Somnolence — 2 reports (10%)
- Abdominal Pain Upper — 1 report (5%)
- Arrhythmia — 1 report (5%)
Other Other approved in United States
Frequently asked questions
Is Gelol approved in United States?
Gelol does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Gelol in United States?
Laboratorio Brasileiro de Biologia is the originator. The local marketing authorisation holder may differ — check the official source linked above.